Influences of obesity on the immunogenicity of Hepatitis B vaccine [PDF]
Human Vaccines & Immunotherapeutics, 2017 Objective: Hepatitis B vaccine is regarded as the most effective method for the prevention of hepatitis B virus (HBV) infection. However, several factors such as age, body mass index and immunocompetent state have been reported to be associated with ...
Fang Liu, Zhirong Guo, Chen Dong
doaj +2 more sources
HBV Vaccines: Advances and Development
Vaccines, 2023 Hepatitis B virus (HBV) infection is a global public health problem that is closely related to liver cirrhosis and hepatocellular carcinoma (HCC). The prevalence of acute and chronic HBV infection, liver cirrhosis, and HCC has significantly decreased as ...
Faisal Mahmood +9 more
doaj +1 more source
Low levels of vaccine coverage and immunity against hepatitis B virus in children with hematological malignancies in Brazil. [PDF]
Braz J Infect DisKrüger VM, da Silva AL, Goldani LZ.
europepmc +2 more sources
Asian Journal of Medical Sciences, 2023 Background: Hepatitis B virus (HBV) infection affects more than 2 billion individuals globally HBV. The chance of dying from liver cirrhosis, acute fulminant liver disease, or hepatocellular carcinoma (HCC) is present in 240 million of these chronic HBV ...
Ramesh Thanikachalam +2 more
doaj +1 more source
Pediatric Discovery, 2023 Our aim is an achievement of a 100 percent vaccination rate without toxic vaccine effects. We did a comprehensive literature review on aluminum neurotoxicity and early neonatal hepatitis B vaccination.
Aleksandar Cirovic +3 more
doaj +1 more source
EVALUATION OF VACCINATION RESPONSE IN CHILDREN AFTER TREATMENT FOR ACUTE LEUKEMIA
Hematology, Transfusion and Cell Therapy, 2021 Objective: Our study aims to evaluate the patients’ immunity regarding childhood vaccination after leukemia treatment and determine the vaccines that require additional doses. Methodology: Sixty-six patients who were followed up with the diagnosis of ALL
Elif KILIC KONTE +4 more
doaj +1 more source
METHODS FOR ASSESSMENT OF THE SPECIFIC ACTIVITY OF DRUGS FOR PREVENTION OF HEPATITIS B
Вопросы вирусологии, 2017 The immunologic activity (specific activity) is one of the main indicators of quality of vaccines for prophylaxis of hepatitis B, along with their safety.
E. L. Postnova +3 more
doaj +1 more source
A Pre-Clinical Safety Evaluation of SBP (HBsAg-Binding Protein) Adjuvant for Hepatitis B Vaccine. [PDF]
PLoS ONE, 2017 Although adjuvants are a common component of many vaccines, there are few adjuvants licensed for use in humans due to concerns about their toxic effects.
Jingbo Wang +6 more
doaj +1 more source
Prophylactic cancer vaccines: development and challenges for HBV and HPV vaccines in Latin America
Salud Pública de México, 2023 Vaccines against hepatitis B virus (HBV) and human papillomaviruses (HPV) are two safe and highly effective vaccines that were developed at the end of the 20th century and can prevent human cancer.
Laura Ximena Ramírez-López +4 more
doaj +1 more source
Hepatitis B Vaccination Coverage among Healthcare Workers and Evaluation of Immune Response by Estimating Anti-HBs Antibody Titers over Time at a Tertiary Care Hospital: A Cross-sectional Study [PDF]
Journal of Clinical and Diagnostic ResearchIntroduction: Healthcare Workers (HCWs) are at a high-risk of acquiring Hepatitis B Virus (HBV) infection. However, this risk can be prevented through Hepatitis B vaccination.
PRIYANKA SONI +6 more
doaj +1 more source